These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31950503)

  • 61. Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death.
    Velma GR; Krider IS; Alves ETM; Courey JM; Laham MS; Thatcher GRJ
    J Med Chem; 2024 Apr; 67(8):5999-6026. PubMed ID: 38580317
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review.
    Gasparrini M; Giovannuzzi S; Nocentini A; Raffaelli N; Supuran CT
    Expert Opin Ther Pat; 2024 Jul; 34(7):565-582. PubMed ID: 38861278
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Local Targeting of NAD
    Li M; Kirtane AR; Kiyokawa J; Nagashima H; Lopes A; Tirmizi ZA; Lee CK; Traverso G; Cahill DP; Wakimoto H
    Cancer Res; 2020 Nov; 80(22):5024-5034. PubMed ID: 32998997
    [TBL] [Abstract][Full Text] [Related]  

  • 64. NAD metabolism fuels human and mouse intestinal inflammation.
    Gerner RR; Klepsch V; Macheiner S; Arnhard K; Adolph TE; Grander C; Wieser V; Pfister A; Moser P; Hermann-Kleiter N; Baier G; Oberacher H; Tilg H; Moschen AR
    Gut; 2018 Oct; 67(10):1813-1823. PubMed ID: 28877980
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nicotinamide phosphoribosyl transferase (Nampt) is required for de novo lipogenesis in tumor cells.
    Bowlby SC; Thomas MJ; D'Agostino RB; Kridel SJ
    PLoS One; 2012; 7(6):e40195. PubMed ID: 22768255
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardiomyocyte Differentiation Promotes Cell Survival During Nicotinamide Phosphoribosyltransferase Inhibition Through Increased Maintenance of Cellular Energy Stores.
    Kropp EM; Broniowska KA; Waas M; Nycz A; Corbett JA; Gundry RL
    Stem Cells Transl Med; 2017 Apr; 6(4):1191-1201. PubMed ID: 28224719
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nicotinamide phosphoribosyltransferase postpones rat bone marrow mesenchymal stem cell senescence by mediating NAD
    Pi C; Yang Y; Sun Y; Wang H; Sun H; Ma M; Lin L; Shi Y; Li Y; Li Y; He X
    Aging (Albany NY); 2019 Jun; 11(11):3505-3522. PubMed ID: 31175267
    [No Abstract]   [Full Text] [Related]  

  • 68. NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity.
    Zou XD; Guo SQ; Hu ZW; Li WL
    Mol Med Rep; 2016 May; 13(5):4058-64. PubMed ID: 27035562
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Targeting the vulnerability to NAD
    Takao S; Chien W; Madan V; Lin DC; Ding LW; Sun QY; Mayakonda A; Sudo M; Xu L; Chen Y; Jiang YY; Gery S; Lill M; Park E; Senapedis W; Baloglu E; Müschen M; Koeffler HP
    Leukemia; 2018 Mar; 32(3):616-625. PubMed ID: 28904384
    [TBL] [Abstract][Full Text] [Related]  

  • 70. NAD
    Moore AM; Zhou L; Cui J; Li L; Wu N; Yu A; Poddar S; Liang K; Abt ER; Kim S; Ghukasyan R; Khachatourian N; Pagano K; Elliott I; Dann AM; Riahi R; Le T; Dawson DW; Radu CG; Donahue TR
    Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33597293
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of NAD+-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models.
    McKay-Corkum GB; Collins VJ; Yeung C; Ito T; Issaq SH; Holland D; Vulikh K; Zhang Y; Lee U; Lei H; Mendoza A; Shern JF; Yohe ME; Yamamoto K; Wilson K; Ji J; Karim BO; Thomas CJ; Krishna MC; Neckers LM; Heske CM
    Clin Cancer Res; 2023 Nov; 29(21):4479-4491. PubMed ID: 37616468
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of NAMPT markedly enhances plasma-activated medium-induced cell death in human breast cancer MDA-MB-231 cells.
    Nagaya M; Hara H; Kamiya T; Adachi T
    Arch Biochem Biophys; 2019 Nov; 676():108155. PubMed ID: 31628926
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitors.
    Shames DS; Elkins K; Walter K; Holcomb T; Du P; Mohl D; Xiao Y; Pham T; Haverty PM; Liederer B; Liang X; Yauch RL; O'Brien T; Bourgon R; Koeppen H; Belmont LD
    Clin Cancer Res; 2013 Dec; 19(24):6912-23. PubMed ID: 24097869
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Discovery of potent NAMPT-Targeting PROTACs using FK866 as the warhead.
    Zhang P; Wang W; Guo M; Zhou L; Dong G; Xu D; Sheng C
    Bioorg Med Chem Lett; 2023 Aug; 92():129393. PubMed ID: 37369332
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD
    Guo J; Lam LT; Longenecker KL; Bui MH; Idler KB; Glaser KB; Wilsbacher JL; Tse C; Pappano WN; Huang TH
    Biochem Biophys Res Commun; 2017 Sep; 491(3):681-686. PubMed ID: 28756225
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Loss of NAMPT in aging retinal pigment epithelium reduces NAD
    Jadeja RN; Powell FL; Jones MA; Fuller J; Joseph E; Thounaojam MC; Bartoli M; Martin PM
    Aging (Albany NY); 2018 Jun; 10(6):1306-1323. PubMed ID: 29905535
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibition of nicotinamide phosphoribosyltransferase modifies LPS-induced inflammatory responses of human monocytes.
    Schilling E; Wehrhahn J; Klein C; Raulien N; Ceglarek U; Hauschildt S
    Innate Immun; 2012 Jun; 18(3):518-30. PubMed ID: 21975728
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibition of pre-B cell colony-enhancing factor (PBEF/NAMPT/visfatin) decreases the ability of human neutrophils to generate reactive oxidants but does not impair bacterial killing.
    Roberts KJ; Cross A; Vasieva O; Moots RJ; Edwards SW
    J Leukoc Biol; 2013 Sep; 94(3):481-92. PubMed ID: 23804809
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPT.
    Barraud M; Garnier J; Loncle C; Gayet O; Lequeue C; Vasseur S; Bian B; Duconseil P; Gilabert M; Bigonnet M; Maignan A; Moutardier V; Garcia S; Turrini O; Delpero JR; Giovannini M; Grandval P; Gasmi M; Ouaissi M; Secq V; Poizat F; Guibert N; Iovanna J; Dusetti N
    Oncotarget; 2016 Aug; 7(33):53783-53796. PubMed ID: 27462772
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression.
    Franceschini N; Oosting J; Tamsma M; Niessen B; Bruijn IB; van den Akker B; Kruisselbrink AB; Palubeckaitė I; Bovée JVMG; Cleton-Jansen AM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.